Immunochemical detection of 3-deoxyglucosone in serum

Biochemical and Biophysical Research Communications

Volumn 325, Issue 3, 2004, Pages 1090-1098

  Uchida, Yoshiaki ^a   Kurano, Yoshihiro ^a   Endo, Tomohiro ^a   Aoyama, Misao ^a   Ito, Satoru ^a  

^a FUJIREBIO INC   (Japan)

Author keywords

3 Deoxyglucosone; Diabetes mellitus; Diabetic complications; Sandwich CLEIA

Indexed keywords

3 DEOXYGLUCOSONE; BENZENE; BIOTIN; DIAMINE DERIVATIVE; MONOCLONAL ANTIBODY; QUINOXALINE DERIVATIVE; STREPTOZOCIN;

ARTICLE; BIOACCUMULATION; BLOOD CHEMISTRY; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS LINKING; DIABETES MELLITUS; EXTRACTION; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOASSAY; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; REACTION ANALYSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOENZYME TECHNIQUES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREPTOZOCIN;

EID: 8444247825     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.131     Document Type: Article

References (29)

1. D. Shin, F. Hayase, and H. Kato Polymerization of proteins caused by reaction with sugars and the formation of 3-deoxyglucosone under physiological conditions Agric. Biol. Chem. 52 1988 1451 1458
2. W. Che, M. Asahi, M. Takahashi, H. Kaneto, A. Okado, S. Higashiyama, and N. Taniguchi Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes J. Biol. Chem. 272 1997 18453 18459
3. C.F. Semenkovich, and J.W. Heinecke The mystery of diabetes and atherosclerosis: time for a new plot Diabetes 46 1997 327 334
4. K.J. Knecht, M.S. Feather, and J.W. Baynes Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo Arch. Biochem. Biophys. 294 1992 130 137
5. S. Tsukushi, T. Katsuzaki, I. Aoyama, F. Takayama, T. Miyazaki, K. Shimokata, and T. Niwa Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway Kidney Int. 55 1999 1970 1976
6. T. Niwa 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication J. Chromatogr. B Biomed. Sci. Appl. 731 1999 23 36
7. E.A. Abordo, H.S. Minhas, and P.J. Thornalley Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity Biochem. Pharmacol. 58 1999 641 648
8. T. Miyata, C. van Ypersele de Strihou, K. Kurokawa, and J.W. Baynes Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications Kidney Int. 55 1999 389 399
9. A. Okado, Y. Kawasaki, Y. Hasuike, M. Takahashi, T. Teshima, J. Fujii, and N. Taniguchi Induction of apoptotic cell death by methylglyoxal and3-deoxyglucosone in macrophage-derived cell lines Biochem. Biophys. Res. Commun. 225 1996 219 224
10. U.J. Eriksson, P. Wentzel, H.S. Minhas, and P.J. Thornalley Teratogenicity of 3-deoxyglucosone and diabetic embryopathy Diabetes 47 1998 1960 1966
11. H. Vlassara, L.J. Striker, S. Teichberg, H. Fuh, Y.M. Li, and M. Steffes Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats Proc. Natl. Acad. Sci. USA 91 1994 11704 11708
12. C.W. Yang, H. Vlassara, E.P. Peten, C.J. He, G.E. Striker, and L.J. Striker Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease Proc. Natl. Acad. Sci. USA 91 1994 9436 9440
13. H. Kato, N. van Chuyen, T. Shinoda, F. Sekiya, and F. Hayase Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats Biochim. Biophys. Acta 1035 1990 71 76
14. H. Yamada, S. Miyata, N. Igaki, H. Yatabe, Y. Miyauchi, T. Ohara, M. Sakai, H. Shoda, M. Oimomi, and M. Kasuga Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction J. Biol. Chem. 269 1994 20275 20280
15. T. Niwa, N. Takeda, H. Yoshizumi, A. Tatematsu, M. Ohara, S. Tomiyama, and K. Niimura Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum Biochem. Biophys. Res. Commun. 196 1993 837 843
16. E. Fujii, H. Iwase, I. Ishii-Karakasa, Y. Yajima, and K. Hotta Quantitation of the glycation intermediate 3-deoxyglucosone by oxidation with rabbit liver oxoaldehyde dehydrogenase to 2-keto-3-deoxygluconic acid followed by high-performance liquid chromatography J. Chromatogr. B Biomed. Appl. 660 1994 265 270
17. H. Khadem, D. Horton, and M. Meshreki New route for synthesis of 3-deoxyaldos-2-uloses Carbohydr. Res. 17 1971 183 192
18. M. Madson, and M. Feather An improved preparation of 3-deoxy-d-erythro- hexos-2-ulose via the bis(benzoylhydrazone) and some related constitutional studies Carbohydr. Res. 94 1981 183 191
19. E. Miyagawa, A. Yoshiki, N. Fujii, H. Honda, E. Ueno, Y. Kurano, and S. Ito Establishment of monoclonal antibody, gp21-34, against HTLV-II envelope protein (p20E) Hybridoma 17 1998 347 354
20. I. Nishizono, S. Iida, N. Suzuki, H. Kawada, H. Murakami, Y. Ashihara, and M. Okada Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers Clin. Chem. 37 1991 1639 1644
21. M. Takahashi, Y.B. Lu, T. Myint, J. Fujii, Y. Wada, and N. Taniguchi In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification of glycation sites Biochemistry 34 1995 1433 1438
22. Y. Hamada, J. Nakamura, H. Fujisawa, H. Yago, E. Nakashima, N. Koh, and N. Hotta Effects of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients Diabetes Care 20 1997 1466 1469
23. S. Lal, F. Kappler, M. Walker, T.J. Orchard, P.J. Beisswenger, B.S. Szwergold, and T.R. Brown Quantitation of 3-deoxyglucosone levels in human plasma Arch. Biochem. Biophys. 342 1997 254 260
24. L. Feng, G.E. Garcia, Y. Yang, Y. Xia, F.B. Gabbai, O.W. Peterson, J.A. Abraham, R.C. Blantz, and C.B. Wilson Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats J. Clin. Invest. 105 2000 341 350
25. H. Kusunoki, S. Miyata, T. Ohara, B.F. Liu, A. Uriuhara, H. Kojima, K. Suzuki, H. Miyazaki, Y. Yamashita, K. Inaba, and M. Kasuga Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy Diabetes Care 26 2003 1889 1894
26. H. Vlassara, R. Bucala, and L. Striker Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging Lab. Invest. 70 1994 138 151
27. H. Odani, T. Shinzato, Y. Matsumoto, J. Usami, and K. Maeda Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction Biochem. Biophys. Res. Commun. 256 1999 89 93
28. T. Niwa, T. Miyazaki, T. Katsuzaki, N. Tatemichi, and Y. Takei Serum levels of 3-deoxyglucosone and tissue contents of advanced glycation end products are increased in streptozotocin-induced diabetic rats with nephropathy Nephron 74 1996 580 585
29. T. Koschinsky, C.J. He, T. Mitsuhashi, R. Bucala, C. Liu, C. Buenting, K. Heitmann, and H. Vlassara Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy Proc. Natl. Acad. Sci. USA 94 1997 6474 6479